1. HyClone™ HyCell™ TransFx Media Brochure

    Use one GE Healthcare HyCell TransFx media for both transient transfection and production. HyCell TransFx-H (HEK 293) and TransFx-C (CHO) media are optimized for each cell line to reduce testing and validation times from research to scale-up. These regulatory-friendly media were developed through the GE Healthcare Metabolic Pathway Design approach and provide an optimized, nutrient-rich formulation, minimizing the requirements for further supplementation and the need to switch media during the process.

  2. Innovation in Cryopreservation Brochure

    With GE Healthcare HyCryo cryopreservation medium, you can store your samples with even more confidence, knowing that our validated media design advances the post-thaw recovery, viability, and growth of your cells.

  3. HyClone™ Buffers and Process Liquids Brochure

    GE Healthcare Life Sciences HyClone cell culture products deliver validated solutions from small scale to large manufacturing. We help to optimize your process and secure your product by supplying integrated solutions for the biopharmaceutical market.

  4. HyClone™ HyCell™ CHO Medium Brochure

    As one of the leading providers of cell culture products, we continuously invest in product development to provide new, innovative solutions and services to our biopharmaceutical customers. We have more than 45 years of experience of delivering high-performing cell culture products to enable our customers to reach cost savings and productivity gains.

  5. Advanced Biofuel Development Using Parallel Bioreactors Systems

    To make biofuels such as bioethanol and biodiesel competitive with fossil fuels extensive research in the field of process development is needed. Taking into account the special requirements of biofuel production, such as high temperatures, multi-step procedures and anaerobic conditions, effective tools for streamlining development efforts must be provided.

  6. Hyclone Cell Culture Media, Sera And Process Liquids

    In March 2014, GE Healthcare Life Sciences announced the completion of the acquisition of the HyClone cell culture media business  from Thermo Fisher Scientific.  The addition of the HyClone portfolio significantly broadens our existing capabilities in life sciences research and bioprocessing. The result is a comprehensive portfolio of products and services across the whole biomanufacturing workflow, from upstream to downstream, from discovery to commercialization.

  7. ArmorFlex®113 Film Brochure

    At ILC Dover we “create what’s next” by listening to our customers. In response to operators’ input we’ve developed a new addition to the ArmorFlex® family of films – AF 113.

  8. ArmorFlex® Family Of Films Brochure

    At ILC Dover we are always “creating what’s next” by listening carefully to our customers. In response to customer input and emerging regulations, we’ve developed a robust new film to support our DoverPac® Containment Systems.

  9. Efficient, High-Titer Monoclonal Antibody Production In A Fed-Batch Process Using Single-Use Stirred-Tank And Rocking Bioreactor Systems

    This application note shows the feasibility of monoclonal antibody (MAb) production in fed-batch processes using the single-use Xcellerex™ XDR-200 stirred-tank and ReadyToProcess WAVE™ 25 rocking bioreactor systems.

  10. Pharmaceutical Flexible Isolator: FlexiVac™

    In an effort to provide a better solution for containment to the standard PTS/DCS system, FlexiVac™ was developed along with our partners CSV Life Sciences in Italy and Micro-Macinazione S.A. The resulting solution improves the ergonomics of the system while containment levels have been verified to <1.0 µg/m3 on a TWA.

Newsletter Signup
Newsletter Signup
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.